AEON Biopharma ( (AEON) ) just unveiled an announcement.
AEON Biopharma, Inc. announced that its President and CEO, Marc Forth, will resign on April 4, 2025, to pursue another opportunity, though he will remain on the board of directors to provide strategic guidance. The board has appointed Jost Fischer, the current Chairman, as Interim CEO while searching for a permanent replacement, leveraging his extensive leadership experience to ensure continuity.
More about AEON Biopharma
YTD Price Performance: -98.20%
Average Trading Volume: 3,421,532
Technical Sentiment Signal: Buy
Current Market Cap: $7.37M
Learn more about AEON stock on TipRanks’ Stock Analysis page.